Schizophrenia  >>  Invega Sustenna (paliperidone palmitate extended-release 1-month injection)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Invega Sustenna (paliperidone palmitate extended-release 1-month injection) / J&J
NCT01181960: Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations

Completed
N/A
1066
US
Risperidone long acting injectable - New Starts, Risperidone long acting injectable - Continuous Users, Paliperidone Palmitate -New and Continuous Users, Other Antipsychotics - New Starts
Janssen Scientific Affairs, LLC
Schizophrenia, Bipolar Disorder
11/13
11/13

Download Options